Dowling & Yahnke LLC Biocryst Pharmaceuticals Inc Transaction History

Dowling & Yahnke LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$9.5 - $17.24 $104,500 - $189,639	-11,000 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$7.37 - $13.61 $36,850 - $68,050	-5,000 Reduced 31.25%	11,000 $112,000
Q3 2020 Oct 19, 2020	BUY	$3.43 - $5.53 $17,150 - $27,650	5,000 Added 45.45%	16,000 $55,000
Q1 2020 May 15, 2020	BUY	$1.6 - $4.11 $17,600 - $45,210	11,000 New	11,000 $22,000

257

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.42B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

Stay updated on Dowling & Yahnke LLC with notifications on news.